At Salubris Biotherapeutics, Inc. (SalubrisBio)
We work to develop novel therapeutic molecules which provide clinically meaningful improvements in disease burden and quality of life to patients with significant medical needs.
What we do
Salubris Biotherapeutics, Inc. (SalubrisBio) is a science-driven biotechnology company dedicated to the discovery and global development of novel antibody and protein-based therapeutics for the treatment of cancer, cardiovascular and metabolic diseases.
Focuses on oncology and cardiometabolic disease. Together, these disease areas represent two of the most common causes of death in the world today.
Who we are
We are a team brought together by our passion and commitment to excellence in drug discovery and development of novel therapies.